# A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

> **NCT00606346** · — · ACTIVE_NOT_RECRUITING · sponsor: **Janssen Biotech, Inc.** · enrollment: 4970 (actual)

## Conditions studied

- Crohn's Disease
- Ulcerative Colitis
- Indeterminate Colitis
- Inflammatory Bowel Diseases

## Interventions

- **BIOLOGICAL:** Anti TNF therapy including infliximab
- **DRUG:** No Biologics

## Key facts

- **NCT ID:** NCT00606346
- **Lead sponsor:** Janssen Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2007-05-31
- **Primary completion:** 2037-11-15
- **Final completion:** 2038-06-30
- **Target enrollment:** 4970 (ACTUAL)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606346, "A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00606346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*